跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,169 条关于
“Organovo Holdings”
全部
1,169
临床试验
169
药物
63
机构
162
资讯
775
去年
Organovo Appoints Norman Staskey as CFO, Advancing IBD and MASH Programs
去年
Organovo's FXR314 Demonstrates Positive Phase 2 Results in MASH Treatment
去年
Eli Lilly Acquires Organovo's FXR Agonist Program for IBD in $60M Deal
去年
Organovo's FXR314 Demonstrates Liver Fat Reduction in Phase 2 MASH Trial
3个月前
3D Printing Medical Devices Market Poised to Reach $18.61 Billion by 2035, Driven by Personalized Implants and Surgical Innovation
去年
Sareum's SDC-1801 Advances to Phase II Trials for Psoriasis Following Positive Phase I Results
去年
European Commission Approves Novo Holdings' $16.5B Catalent Acquisition
2年前
Bio-Path Holdings' BP1003 Demonstrates Therapeutic Potential in Diverse Cancers
去年
MD Anderson Partners with TOPPAN Holdings to Develop Organoid-Based Personalized Cancer Treatment Platform
2年前
Immunocore and Bristol Myers Squibb Collaborate on Phase 3 Trial for Advanced Cutaneous Melanoma
第 1 页,共 78 页
上一页
下一页